Available until February 1, 2026

Summary: Flu and cold season is an annual concern for people around the world. Specifically in the United States, there are massive disparities in both care and outcomes for communities of color related to both diagnosis and treatment of flu and cold. On this episode of the RISE for Equity podcast, Dr. Nusheen Ameenuddin joins host Nicole Nfonoyim-Hara to discuss COVID’s impact on cold and flu, protecting our communities, and how we can improve education and access to care for marginalized communities. “The truth of the matter is genetically, we're all very similar. It's not an issue of race, it's an issue of racism. When we actually step back, people can be like, ‘Oh, that situation was a one-off.’ And when we actually look at the data, it's not a one-off. The fact is, we're not asking the right questions, and we need to look deeper to ensure that we are providing the best possible care, the most objective care, the most patient-centered care, particularly when we see that we're falling short. And, and the numbers don't lie.” - Dr. Nusheen Ameenuddin Guest: Dr. Nusheen Ameenuddin is currently an Assistant Professor and Consultant (tenured staff physician) in the Division of Community Pediatric and Adolescent Medicine, Department of Pediatrics, at the Mayo Clinic, Rochester, MN. Please visit the RISE for Equity website for more information.

Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until December 31, 2026 - Online CME Course

Mayo Clinic Application of Quality Improvement: Tools and Methods – Silver Level Knowledge Assessment (formerly Applied Quality Essentials) is a learning and self-assessment activity which aims to evaluate the participant’s knowledge in quality improvement concepts and methods. This Silver Level Knowledge Assessment crosses all disciplines and clinical settings. The following key themes align with ABMS patient safety standards document and are incorporated in the questions and reference material for this module: patient safety, error identification, effect of systems, human factors, communication, culture of safety, methods and tools for evaluating quality and safety events. There are no prerequisites for this course. The module is offered as an online 30-question Pre-test (Test A) and 30-question Post-test (Test B). Test A and Test B are different versions each containing 30 distinct questions testing to the same concepts. The module can be taken as an open book test with an extensive, indexed Study Guide included. Education credit will be awarded if the participant achieves a score ≥80% correct answers on Pre-test (Test A-one chance) or Post-test (Test B-two chances). For Test A, the learner’s choices along with the correct answers for each question will be provided with an overall performance score and relevant references to educational content at the conclusion of the test. For Test B, the learner can choose to display whether the answer was correct or incorrect, with an overall performance score at the conclusion of the test.

Available until January 23, 2027 - Podcast Online CME Education

Krysta Larson, PharmD provides updates on heart failure treatment strategies in transitions of care.

Available until February 6, 2027 - Podcast Online CME Education

Andrea Aguayo, PharmD provides insights on statin intolerance and alternative approaches.

Available until February 20, 2027 - Podcast Online CME Education

Megan Edwards, PharmD shares insights on navigating infection risk with advanced therapies for inflammatory bowel disease.